The largest database of trusted experimental protocols

Anti cd64 apc vio770

Manufactured by Miltenyi Biotec
Sourced in Germany, United States

The Anti-CD64-APC-Vio770 is a flow cytometry reagent that detects the expression of CD64 (Fc gamma RI) on the surface of cells. CD64 is a high-affinity Fc receptor that binds the Fc portion of IgG antibodies. This reagent can be used to identify cells expressing CD64, which is important in various immune and inflammatory processes.

Automatically generated - may contain errors

3 protocols using anti cd64 apc vio770

1

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cervical lymph node cells were isolated, washed, counted, and resuspended at 100,000 cells in 50 μL of flow cytometry buffer. Cells were treated with FcR-block (Miltenyi Biotec, Bergisch Gladbach, Germany) and labeled for surface markers via antibodies, per the manufacturer’s instructions31 (link),39 (link). Dead cells were excluded from analysis by labeling with propidium iodide viability dye (Miltenyi Biotec), per the manufacturer’s instructions31 (link),39 (link). Neutrophils: anti-CD11b-APC (Miltenyi Biotec; clone REA592), anti-Ly6C-FITC (Miltenyi Biotec; clone REA796), anti-Ly6G-VioBlue (Miltenyi Biotec; clone 1A8). M1-macrophages: anti-CD11b-APC (Miltenyi Biotec; clone REA592), anti-MHC II-FITC (Miltenyi Biotec; clone REA528), anti-CD206-PE (Miltenyi Biotec; clone MR6F3), anti-CD64-APC-Vio770 (Miltenyi Biotec; clone REA286). Plasmacytoid dendritic cells: anti-CD11c-PE-Vio770 (Miltenyi Biotec; clone REA754), anti-MHC II-FITC (Miltenyi Biotec; clone REA528), anti-B220-VioBlue (Miltenyi Biotec; clone REA755). A minimum of 5,000 gated cells were analyzed per specimen. Data was acquired by the MACSQuant System (Miltenyi Biotec) and analyses were performed via FlowJo 11.0 software (TreeStar, Ashland, OR, USA), as previously reported31 (link),39 (link).
+ Open protocol
+ Expand
2

In Vitro Macrophage Polarization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro macrophage induction, purified CD14+ monocytes were cultured in a complete RPMI medium (Life Technologies, Bleiswijk, The Netherlands) supplemented with 10% heat-inactivated calf serum (Merck Life Science, Madrid, Spain), 2 mM L-glutamine (Merck Life Science, Madrid, Spain), 1% antibiotic/antimycotic solution, and 100 ng/mL Macrophage Colony-Stimulating Factor (M-CSF) (Miltenyi Biotec, Bergisch Gladbach, Germany) for 8 days. Afterwards, M0 macrophages were polarized towards a M1 phenotype by incubating them with 120 ng/mL of IFNγ and 10 ng/mL of Lipopolysaccharides (LPS) (Merck Life Science, Madrid, Spain) for 48 h. For M2 phenotype, M0 macrophages were incubated with 2 µg/mL IL-4 (Peprotech, London, UK) for 48 h. MSCs were co-cultured with either M0, M1, or M2 macrophages at a ratio of 1:1. After 2 days macrophages were stained with the following antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany): anti-CD163-APC, anti-CD64-APC-Vio770, anti-CD209-PE-Vio770, anti-CD86-FITC, anti-MHC-I- PeVio770, anti-CD206 VioBlue, or with the corresponding isotype control antibodies. Data were acquired by flow cytometry using the MACSQuant® analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany). Data were analyzed using MACSQuantify software (Miltenyi Biotec, Bergisch Gladbach, Germany) and FlowJoTM v10.6.2 Software (BD Life Sciences, Ashland, OR, USA).
+ Open protocol
+ Expand
3

Immune Cell Subset Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with FcR‐block (Miltenyi Biotec) and stained for cell surface markers. Myeloid‐derived suppressor cells (MDSCs): anti‐CD11b‐APC (Miltenyi Biotec; clone REA592), anti‐Ly6G‐VioBlue (Miltenyi Biotec; clone 1A8), anti‐F4/80‐PE (Miltenyi Biotec; clone REA126), anti‐Ly6C‐FITC (Miltenyi Biotec; clone REA796). Plasmacytoid dendritic cells (pDC): anti‐CD11c‐PE‐Vio770 (Miltenyi Biotec; clone REA754), anti‐MHC II‐FITC (Miltenyi Biotec; clone REA528), anti‐B220‐VioBlue (Miltenyi Biotec; clone REA755). M1/M2 macrophages: anti‐CD11b‐APC (Miltenyi Biotec; clone REA592), anti‐CD11c‐PE‐Vio770 (Miltenyi Biotec; clone REA754), anti‐MHC class II‐FITC (Miltenyi Biotec; clone REA528), anti‐CD64‐APC‐Vio770 (Miltenyi Biotec; clone REA286), anti‐B220‐VioBlue (Miltenyi Biotec; clone REA755), anti‐CD206‐PE (eBioscience, Santa Clara, CA, USA; clone MR6F3). Dead cells were excluded from analysis via propidium iodide viability dye (Miltenyi Biotec).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!